[Enhancement of the antitumor activity of bleomycin A5 by 3-aminobenzamide in vitro and in vivo].
G
G
Chen
Q C
QC
Pan
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use* / Q000031:analogs & derivatives; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D012510:Sarcoma 180 / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D001549:Benzamides; D001761:Bleomycin; C025703:bleomycetin; C025160:3-aminobenzamide